申请人:Lundbeck; H.
公开号:US05665725A1
公开(公告)日:1997-09-09
Piperidine compounds having the general formula (I), ##STR1## wherein R.sup.1 is a group having general formula (II), ##STR2## wherein X is CHR.sup.10, O, S, SO, SO.sub.2 or NR.sup.10, Z.sup.1 is CH.sub.2, O, or S; Z.sup.2 and Z.sup.3 are independently (CH.sub.2).sub.n, n being 0 or 1, O or S or Z.sup.1 and Z.sup.2 may together represent a group --CH.dbd.CH--; or when Z.sup.3 is (CH.sub.2).sub.n wherein n is 0, Z.sup.1 and Z.sup.2 may together represent a 3-membered divalent group; show potent sigma receptor activity. Furthermore they show effect in animal models indicative of anxiolytic properties. Accordingly they are useful as medicines for the treatment of anxiety, psychosis, epilepsy, convulsion, movement disorders, motor disturbances, amnesia, cerebrovascular diseases, senile demential of the Alzheimer type or Parkinson's disease.
哌啶化合物具有通式(I),其中 R.sup.1 是具有通式(II)的基团,其中 X 是CHR.sup.10,O,S,SO,SO.sub.2或NR.sup.10,Z.sup.1是CH.sub.2,O或S;Z.sup.2和Z.sup.3分别为(CH.sub.2).sub.n,n为0或1,O或S或Z.sup.1和Z.sup.2可以共同表示一个羟基;或者当Z.sup.3是(CH.sub.2).sub.n时,其中n为0,Z.sup.1和Z.sup.2可以共同表示一个3-成员双价基团;显示出强大的σ受体活性。此外,它们在动物模型中显示出具有抗焦虑特性的效果。因此,它们可用作治疗焦虑症、精神病、癫痫、抽搐、运动障碍、运动紊乱、健忘症、脑血管疾病、老年性阿尔茨海默病或帕金森病的药物。